Talking Techniques | Rob Vries on organoids for drug discovery and the study of COVID-19
BioTechniques Digital Editor, Tristan Free, speaks to Rob Vries, CEO of Hubrecht Organoid Technology (Utrecht, Netherlands) otherwise known as the HUB. We explore the HUB’s use of organoids for drug development and to further study and improve the clinical treatments of diseases such as cystic fibrosis. After an analysis of the advantages of organoids over … Continue reading Talking Techniques | Rob Vries on organoids for drug discovery and the study of COVID-19
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed